Intuitive Surgical trades at a 50x price-to-earnings ratio, higher than Nvidia's 31x. Despite the richer valuation, the medical device maker's current P/E is below its five-year average of nearly 70%. Intuitive Surgical leads in robotic surgery, a market tied to the human body, which changes slowly compared to AI chip technology.
Tracked by ByteBrief